Tumor necrosis factor receptor 2 activation elicits sex-specific effects on cortical myelin proteins and functional recovery in a model of multiple sclerosis. Brain research bulletin, (207):110885--110885, United States, January 2024. [PUMA: izi 2024 pfizenmaier kontermann] URL
The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration. Scientific reports, (13)1:10622--10622, England, June 2023. [PUMA: izi 2023 pfizenmaier kontermann] URL
An XBP-1 dependent bottle-neck in production of IgG subtype antibodies in chemically defined serum-free Chinese hamster ovary (CHO) fed-batch processes. Journal of Biotechnology, (135)2:217--223, Elsevier BV, June 2008. [PUMA: 2008 izi pfizenmaier] URL
G-PKDrep-live, a genetically encoded FRET reporter to measure PKD activity at the trans-Golgi-network. Biotechnology Journal, (7)1:148--154, January 2012. [PUMA: izi 2012 pfizenmaier hausser] URL
A mouse bone marrow stromal cell line with skeletal stem cell characteristics to study osteogenesis in vitro and in vivo.. Stem cells and development, (23)10:1097--108, May 2014. [PUMA: izi 2014 pfizenmaier hausser] URL
Therapeutic Targeting of CD95 and the TRAIL Death Receptors. Recent Patents on Anti-Cancer Drug Discovery, (6)3:294--310, 2011. [PUMA: izi 2011 pfizenmaier] URL
Antiestrogens induce transforming growth factor $\beta$-mediated immunosuppression in breast cancer. Cancer Research, (70)4:1314--1322, 2010. [PUMA: izi pfizenmaier 2010] URL
Selective targeting of TNF receptors as a novel therapeutic approach. Frontiers in Cell and Developmental Biology, (8)Frontiers, 2020. [PUMA: izi fischer pfizenmaier 2020 kontermann] URL
Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cells. Journal of Controlled Release, (137)1:69--77, 2009. [PUMA: 2009 izi pfizenmaier kontermann] URL
Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomib. Hepatology, (57)2:625--636, February 2013. [PUMA: izi 2013 pfizenmaier kontermann] URL
An optimized antibody-single-chain TRAIL fusion protein for cancer therapy. mAbs, (8)5:879--891, July 2016. [PUMA: 2016 izi pfizenmaier kontermann] URL
Tetravalent Antibody-scTRAIL Fusion Proteins with Improved Properties. Molecular Cancer Therapeutics, (13)1:101--111, January 2014. [PUMA: izi 2014 pfizenmaier kontermann] URL
Global Detection of Protein Kinase D-dependent Phosphorylation Events in Nocodazole-treated Human Cells. Molecular & Cellular Proteomics, (11)5:160--170, May 2012. [PUMA: izi 2012 pfizenmaier hausser] URL
Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles. Bioconjugate Chemistry, (25)5:879--887, May 2014. [PUMA: izi 2014 pfizenmaier kontermann] URL
OMTX705, a Novel FAP-Targeting ADC demonstrates Activity in Chemotherapy and PD1-Resistant Solid Tumors Models. Clinical Cancer Research, clincanres.2238.2019, Clin Cancer Res, March 2020. [PUMA: izi pfizenmaier 2020 kontermann] URL
A Golgi PKD activity reporter reveals a crucial role of PKD in nocodazole-induced Golgi dispersal. Traffic, (10)7:858--867, 2009. [PUMA: 2009 izi pfizenmaier hausser] URL
A Novel Functional Polymorphism in the Transforming Growth Factor-β2 Gene Promoter and Tumor Progression in Breast Cancer. Cancer Research, (66)15:7554--7561, August 2006. [PUMA: 2006 izi pfizenmaier] URL
Selective activation of tumor necrosis factor receptor 2 induces anti-inflammatory responses and alleviates experimental arthritis. Arthritis & Rheumatology, January 2018. [PUMA: 2018 izi pfizenmaier kontermann] URL
Protein kinase D controls the integrity of Golgi apparatus and the maintenance of dendritic arborization in hippocampal neurons.. Molecular biology of the cell, (20)7:2108--20, 2009. [PUMA: 2009 izi pfizenmaier hausser] URL
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L. Cell Death and Differentiation, (14)12:2021--2034, 2007. [PUMA: 2007 izi pfizenmaier] URL